Hormone therapy during menopause raises breast cancer risk for years, study finds
The longer women used hormone therapy during menopause, the greater their risk of breast cancer. And even those who stopped taking it remained at an elevated risk for more than…
by Megan Thielking
Aug 29, 2019
3 minutes
![](https://article-imgs.scribdassets.com/1f33nbemps77gkfw/images/file1FL5ECYQ.jpg)
A sweeping new analysis adds to the evidence that many women who take hormone therapy during menopause are more likely to develop breast cancer — and remain at higher risk of cancer for more than a decade after they stop taking the drugs.
The study, published Thursday in , looked at data from dozens of studies, including long-term data on more than 100,000 women who developed breast cancer after menopause. Half of those women had used what’s known as menopausal hormone therapy, or MHT. The
You’re reading a preview, subscribe to read more.
Start your free 30 days